Stocktoria
KIORA PHARMACEUTICALS INC KPRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-02-13
KIORA PHARMACEUTICALS INC statistics & valuation
Market cap$11.3M
P / B0.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | 28.2% | — | — | — |
| Net margin | — | 22.4% | — | — | — |
| FCF margin | — | 53.4% | — | — | — |
| Return on assets | -44.7% | 9.9% | -91.3% | -72.7% | -68.4% |
| Return on equity | -67.2% | 14.0% | -204.8% | -119.1% | -94.5% |
| Current ratio | 5.99 | 4.94 | 2.90 | 2.35 | 5.59 |
| Revenue growth | -100.0% | — | — | — | -100.0% |
Source: SEC EDGAR filings · CIK 0001372514 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.